EASTSIDE DISTILLING INC (EAST)

US2778024016 - Common Stock

1.02  -0.04 (-3.77%)

After market: 1.0899 +0.07 (+6.85%)

Fundamental Rating

2

Overall EAST gets a fundamental rating of 2 out of 10. We evaluated EAST against 33 industry peers in the Beverages industry. EAST may be in some trouble as it scores bad on both profitability and health. EAST has a decent growth rate and is not valued too expensively.



0

1. Profitability

1.1 Basic Checks

In the past year EAST has reported negative net income.
EAST had a negative operating cash flow in the past year.
In the past 5 years EAST always reported negative net income.
In the past 5 years EAST always reported negative operating cash flow.

1.2 Ratios

EAST has a Return On Assets of -43.99%. This is amonst the worse of the industry: EAST underperforms 84.85% of its industry peers.
EAST has a Return On Equity of -901.41%. This is amonst the worse of the industry: EAST underperforms 84.85% of its industry peers.
Industry RankSector Rank
ROA -43.99%
ROE -901.41%
ROIC N/A
ROA(3y)-44.62%
ROA(5y)-42.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

EAST's Gross Margin of 10.14% is on the low side compared to the rest of the industry. EAST is outperformed by 93.94% of its industry peers.
EAST's Gross Margin has declined in the last couple of years.
EAST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.87%
GM growth 5Y-23.17%

1

2. Health

2.1 Basic Checks

EAST does not have a ROIC to compare to the WACC, probably because it is not profitable.
EAST has more shares outstanding than it did 1 year ago.
EAST has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EAST has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -6.92, we must say that EAST is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.92, EAST is doing worse than 81.82% of the companies in the same industry.
EAST has a Debt/Equity ratio of 12.42. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 12.42, EAST is doing worse than 84.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 12.42
Debt/FCF N/A
Altman-Z -6.92
ROIC/WACCN/A
WACC5.77%

2.3 Liquidity

EAST has a Current Ratio of 1.08. This is a normal value and indicates that EAST is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.08, EAST is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
EAST has a Quick Ratio of 1.08. This is a bad value and indicates that EAST is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.32, EAST is doing worse than 78.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.32

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.99% over the past year.
EAST shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.44%.
EAST shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.40% yearly.
EPS 1Y (TTM)70.99%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q88.79%
Revenue 1Y (TTM)-24.44%
Revenue growth 3Y-9.17%
Revenue growth 5Y11.4%
Revenue growth Q2Q-13.33%

3.2 Future

The Earnings Per Share is expected to grow by 40.83% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 80.07% on average over the next years. This is a very strong growth
EPS Next Y105.47%
EPS Next 2Y40.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year100.7%
Revenue Next 2Y80.07%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EAST. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 3.03, the valuation of EAST can be described as very cheap.
Based on the Price/Forward Earnings ratio, EAST is valued cheaper than 100.00% of the companies in the same industry.
EAST is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.02, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 3.03

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EAST's earnings are expected to grow with 40.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.83%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EAST!.
Industry RankSector Rank
Dividend Yield N/A

EASTSIDE DISTILLING INC

NASDAQ:EAST (4/30/2024, 7:00:02 PM)

After market: 1.0899 +0.07 (+6.85%)

1.02

-0.04 (-3.77%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.74M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.03
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -43.99%
ROE -901.41%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 10.14%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 12.42
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.08
Quick Ratio 0.32
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)70.99%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y105.47%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-24.44%
Revenue growth 3Y-9.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y